SEARCH

SEARCH BY CITATION

References

  • 1
    Shimizu S, Shimizu T, Morser J, Kobayashi T, Yamaguchi A, Qin L, Toda M, D’Alessandro-Gabazza C, Maruyama T, Takagi T, Yano Y, Sumida Y, Hayashi T, Yano Y, Sumida Y, Hayashi T, Takei Y, Taguchi O, Suzuki K, Gabazza EC. Role of the coagulation system in allergic inflammation in the upper airways. Clin Immunol 2008; 129: 36571.
  • 2
    Tamagawa-Mineoka R, Katoh N, Kishimoto S. Platelets play important roles in the late phase of the immediate hypersensitivity reaction. J Allergy Clin Immunol 2009; 123: 5817.
  • 3
    Wojta J, Kaun C, Zorn G, Ghannadan M, Hauswirth AH, Sperr WR, Fritsch G, Printz G, Blinder BR, Schatzl G, Zwirner J, Maurer G, Huber K, Valent P. C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils. Blood 2002; 100: 51723.
  • 4
    Hamuro T, Kido H, Asada Y, Hatakeyama K, Okumura Y, Kunori Y, Kamimuri T, Iwanaga S, Kamei S. Tissue factor pathway inhibitor is highly susceptible to chymase-mediated proteolysis. FEBS J 2007; 274: 306577.
  • 5
    Nastalek M, Wojas-Pelc A, Undas A. Plasma fibrin clot properties in atopic dermatitis: links between atopy and thrombosis. J Thromb Thrombolysis 2010; 30: 1216.
  • 6
    Undas A, Zawilska K, Ciesla-Dul M, Lehmann-Kopydłowska A, Skubiszak A, Ciepłuch K, Tracz W. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives. Blood 2009; 114: 42728.
  • 7
    Lisman T, Leebeek FW, Mosnier LO, Bouma BN, Meijers JC, Janssen HL, Nieuwenhuis HK, De Groot PG. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology 2001; 121: 1319.
  • 8
    Meltzer ME, Lisman T, de Groot PG, Meijers JC, le Cessie S, Doggen CJ, Rosendaal FR. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood 2010; 116: 11321.
  • 9
    Pampuch A, Kowal K, Bodzenta-Lukaszyk A, Di Castelnuovo A, Chyczewski L, Doinati MB. The –675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients. Allergy 2006; 61: 2348.
  • 10
    Reitsma PH, Rosendaal FR. Past and future of genetic research in thrombosis. J Thromb Haemost 2007; 5(Suppl. 1): 2649.